GLP1R
Glucagon-like peptide 1 receptor
Also known as: GLP-1R, GLP1R_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43220
- Gene
- GLP1R
- Ensembl
- ENSG00000112164
- Chromosome
- 6
- Canonical length
- 463 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a 7-transmembrane protein that functions as a receptor for glucagon-like peptide 1 (GLP-1) hormone, which stimulates glucose-induced insulin secretion. This receptor, which functions at the cell surface, becomes internalized in response to GLP-1 and GLP-1 analogs, and it plays an important role in the signaling cascades leading to insulin secretion. It also displays neuroprotective effects in animal models. Polymorphisms in this gene are associated with diabetes. The protein is an important drug target for the treatment of type 2 diabetes and stroke. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
463 residues, UniProt reviewed canonical sequence.
>P43220|GLP1R
1 MAGAPGPLRL ALLLLGMVGR AGPRPQGATV SLWETVQKWR EYRRQCQRSL TEDPPPATDL
61 FCNRTFDEYA CWPDGEPGSF VNVSCPWYLP WASSVPQGHV YRFCTAEGLW LQKDNSSLPW
121 RDLSECEESK RGERSSPEEQ LLFLYIIYTV GYALSFSALV IASAILLGFR HLHCTRNYIH
181 LNLFASFILR ALSVFIKDAA LKWMYSTAAQ QHQWDGLLSY QDSLSCRLVF LLMQYCVAAN
241 YYWLLVEGVY LYTLLAFSVL SEQWIFRLYV SIGWGVPLLF VVPWGIVKYL YEDEGCWTRN
301 SNMNYWLIIR LPILFAIGVN FLIFVRVICI VVSKLKANLM CKTDIKCRLA KSTLTLIPLL
361 GTHEVIFAFV MDEHARGTLR FIKLFTELSF TSFQGLMVAI LYCFVNNEVQ LEFRKSWERW
421 RLEHLHIQRD SSMKPLKCPT SSLSSGATAG SSMYTATCQA SCSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLP1R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 8.6 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 8.6 nTPM
- heart muscle: 2.6 nTPM
- salivary gland: 2.1 nTPM
- hypothalamus: 1.5 nTPM
- basal ganglia: 1.3 nTPM
- cerebral cortex: 1.2 nTPM
Single-cell type
- tuft cells: 46 nCPM
- pancreatic islet cells: 23 nCPM
- lacrimal acinar cells: 19 nCPM
- pancreatic acinar cells: 16 nCPM
- other brain neurons: 11 nCPM
- neuroendocrine cells: 8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 8.2 nTPM
- pons: 3.2 nTPM
- medulla oblongata: 2.9 nTPM
- spinal cord: 2.8 nTPM
- basal ganglia: 2.3 nTPM
- hippocampal formation: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.29
- gnomAD missense Z
- 1.68
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of adenylate cyclase activity
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- hormone secretion
- learning or memory
- negative regulation of blood pressure
- positive regulation of blood pressure
- positive regulation of cytosolic calcium ion concentration
- post-translational protein targeting to membrane, translocation
- regulation of heart contraction
- response to psychosocial stress
Molecular functions
- glucagon receptor activity
- peptide hormone binding
- transmembrane signaling receptor activity
- glucagon-like peptide 1 receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 2, secretin-like
- GPCR, family 2, extracellular hormone receptor domain
- GPCR, family 2, glucagon-like peptide-1/glucagon receptor
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- GPCR family 2, extracellular hormone receptor domain superfamily
- G-protein coupled receptor 2
- 7 transmembrane receptor (Secretin family)
- Hormone receptor domain
- GPCR, family 2, glucagon-like peptide-1 receptor
- Glucagon-like peptide-1 receptor, 7TM
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLP1R as an antibody target. Whether an autoantibody or antibody against GLP1R could matter depends on whether native GLP1R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLP1R is annotated at the cell surface, where native GLP1R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GLP1R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...